Shi S, Kleyman TR. Gamma subunit second transmembrane domain contributes to epithelial sodium channel gating and amiloride block. Am J Physiol Renal Physiol 305: F1585-F1592, 2013. First published October 9, 2013 doi:10.1152/ajprenal.00337.2013.-The epithelial sodium channel (ENaC) is comprised of three homologous subunits. Channels composed solely of ␣-and ␤-subunits (␣␤-channels) exhibit a very high open probability (P o) and reduced sensitivity to amiloride, in contrast to channels composed of ␣-and ␥-subunits or of all three subunits (i.e., ␣␥-and ␣␤␥-channels). A mutant channel comprised of ␣-and ␤-subunits, and a chimeric ␥-subunit where the region immediately preceding (␤12 and wrist) and encompassing the second transmembrane domain (TM2) was replaced with the corresponding region of the ␤-subunit (␥-␤TM2), displayed characteristics reminiscent of ␣␤-channels, including a reduced amiloride potency of block and a loss of Na ϩ self-inhibition (reflecting an increased Po). Substitutions at key pore-lining residues of the ␥-␤TM2 chimera enhanced the Na ϩ self-inhibition response, whereas key ␥-subunit substitutions reduced the response. Furthermore, multiple sites within the TM2 domain of the ␥-subunit were required to confer high amiloride potency. In summary, we have identified novel pore-lining residues of the ␥-subunit of ENaC that are important for proper channel gating and its interaction with amiloride.
ϩ absorption and volume regulation (ENaCs), mechanosensation (ENaCs and Caenorhabditis elegans degenerins), and nociception [acid-sensing ion channels (ASICs); Refs. 11, 16, 44] . ENaCs are heterotrimeric channels composed of three homologous subunits, termed ␣, ␤, and ␥. The second transmembrane helix from each subunit contributes to the channel pore where the gate, selectivity filter, and amiloride binding site likely reside (16, 32, 37, 43) .
ENaCs with different subunit compositions have been reconstituted in heterologous expression systems (4, 12, 14, 27) . Previous studies by Fyfe and Canessa (12) and by McNicholas and Canessa (27) have shown that rat ENaCs composed solely of ␣-and ␤-subunits exhibit functional properties that differ from channels including the ␥-subunit (i.e., ␣␤␥-channels or ␣␥-channels). When expressed in Xenopus oocytes, ␣␤-channels were more permeable to Na ϩ than Li ϩ and less sensitive to amiloride and related analogs (27) . At the single channel level, the ␣␤-channel displayed a smaller conductance and higher open probability (P o ; Ref. 12 ). These observations suggest that the ␥-subunit has roles in restraining ENaC activity and enhancing the potency of amiloride block on channel activity. However, the sites within the ␥-subunit that account for distinct properties of ␣␤␥-and ␣␥-channels, compared with ␣␤-channels, have not been elucidated.
The functional differences between ␣␤-and ␣␤␥-channels are relevant for a mice model where overexpression of the ␤-subunit results in a lung phenotype similar to that observed in humans with cystic fibrosis, with reduced airway surface liquid volume due to increased ENaC activity (25) . The authors suggested that the presence of ␣␤-channels in airways contributed to this phenotype, reflecting a high baseline P o and a lack of channel inhibition by the cystic fibrosis transmembrane conductance regulator (26) .
In the current study, we generated and examined the properties of channels bearing ␥-␤-chimeric subunits, as well as channels with mutations at specific sites, to define sites within the ␥-subunit that are responsible for conferring the high amiloride potency and the moderate channel P o seen in channels containing a ␥-subunit, compared with ␣␤-channels. We found that the pore-forming region of the ␥-subunit (S529 -I556) contains key sites that contribute to the high amiloride potency and the moderate channel P o .
EXPERIMENTAL PROCEDURES
ENaC subunit domain swap and site-directed mutagenesis. Wildtype ␤-and ␥-subunits of mouse ENaC in pBluescript SK Ϫ vector were used as templates to generate a series of five chimeric ␥-subunits by replacing specific regions of the ␥-subunit with the corresponding regions of the ␤-subunit: 1) the NH 2 terminus and the first transmembrane domain (TM1) of the ␤-subunit were inserted into the ␥-subunit [␥-␤NTM1 (residues ␤1-78 and ␥81-655)], 2) the ␤-subunit extracellular domain (ECD) was inserted into the ␥-subunit [␥-␤ECD (residues ␥1-80, ␤79 -505, and ␥523-655)], 3) the second transmembrane domain (TM2, and the region just preceding TM2) and COOH terminus of the ␤-subunit were inserted into the ␥-subunit [␥-␤TM2C (residues ␥1-522 and ␤506 -638)], 4) the TM2 (and the region just preceding TM2) of the ␤-subunit was inserted into the ␥-subunit [␥-␤TM2 (residues ␥1-522, ␤506 -546 and ␥565-655)], and 5) the COOH terminus of the ␤-subunit was inserted into the ␥-subunit [␥-␤C (residues ␥1-564 and ␤547-638)]. Point mutations of sites within the ␥-␤TM2 chimera or the wild-type ␥-subunit were generated using a QuikChange II XL kit. DNA sequencing was performed to confirm the desired domain swap or targeted point mutations.
ENaC expression in Xenopus oocytes. cRNAs were synthesized with a T3 mMessage mMachine kit (Ambion). Wild-type and mutant ENaCs were expressed in stage V-VI Xenopus oocytes as previously described (41) . After injection, oocytes were maintained at 18°C in modified Barth's saline [88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3, 15 mM HEPES, 0.3 mM Ca(NO 3)2, 0.41 mM CaCl2, 0.82 mM MgSO 4, 10 g/ml sodium penicillin, 10 g/ml streptomycin sulfate, and 100 g/ml gentamycin sulfate, pH adjusted to 7.4 with NaOH]. All experiments were performed at room temperature 20 -28 h following cRNA injection. Na ϩ self-inhibition. The Na ϩ self-inhibition response was measured as previously described (41) . Oocytes were perfused with a high Na ϩ concentration ([Na ϩ ]) bath solution (NaCl-110, containing 110 mM NaCl, 2 mM KCl, 1.6 mM CaCl2, and 10 mM HEPES, pH 7.4) for the first 60 s and then with a low [Na ϩ ] bath solution (NaCl-1, containing 1 mM NaCl, 109 mM N-methyl-D-glucamine, 2 mM KCl, 1.6 mM CaCl2, and 10 mM HEPES, pH adjusted to 7.4 with HCl) for another 60 s. To initiate Na ϩ self-inhibition, the NaCl-1 solution was rapidly replaced by the NaCl-110 solution while whole cell Na ϩ currents were continuously recorded. At the end of each experiment, the oocyte was perfused with 10 M amiloride prepared with the NaCl-110 solution to determine the amiloride-insensitive component of the whole cell current. Oocytes expressing channels with reduced amiloride sensitivity (e.g., ␣␤␥-␤TM2 and ␣␤␥-␤TM2C) were perfused with 10 M benzamil at the end of the experiment. To determine the rate constant of the Na ϩ self-inhibition response (-value), the first 40 s of current decay following the switch to the NaCl-110 solution was fit with an exponential equation using Clampfit 10.2 (Molecular Devices). The maximal inward current immediately after the switch from NaCl-1 to NaCl-110 (I peak) and the steady-state current (I ss) measured 40 s after the Ipeak were obtained. The ratio of the amiloride-sensitive I ss to the amiloride-sensitive Ipeak was used to assess the extent of Na ϩ self-inhibition. Channel activation by laminar shear stress. To measure the effects of laminar shear stress (LSS), oocytes were clamped at a holding potential of Ϫ60 mV while whole cell Na ϩ currents were continuously recorded. LSS stimulation was initiated through a vertical pipette (1.8-mm internal diameter) placed near the surface of the oocyte. The flow rate of the vertical perfusion was adjusted to 1.6 ml/min, corresponding to 0.137 dyn/cm 2 of shear stress as previously described (7) . At the end of each experiment, 10 M benzamil was delivered to the chamber to determine the ENaC specific current. To assess the magnitude of the LSS response, we determined the benzamil-sensitive current just before the initiation of LSS (I basal), and the benzamil-sensitive current measured 40 s following the initiation of LSS (I LSS). The ILSS/Ibasal value was calculated for each recording. The time constant for channel activation ( value) was determined by fitting the first 40 s of current activation measured following the initiation of the vertical perfusion with a single-component exponential equation using Clampfit 10.2 (Molecular Devices) as previously described (7) .
Potency of amiloride block. Oocytes were clamped at Ϫ100 mV while whole cell currents were continuously recorded. In the first 60 s, oocytes were perfused with NaCl-110 to measure basal currents (I 0) in the absence of amiloride. An amiloride stock solution (0.1 M) prepared in DMSO was diluted to a series of concentrations ( 
where X is the concentration of amiloride (M). The IC50 is defined as the concentration of amiloride that inhibits 50% of the whole cell Na ϩ current (y).
Statistical analyses. Data were expressed as the means Ϯ SE. Given the variability in the response of channels to extracellular Na ϩ or amiloride between different batches of oocytes, experiments were repeated using a minimum of two batches of oocytes obtained from different frogs. Electrophysiological data were analyzed with Clampfit 10.2 (Molecular Devices). Statistical comparisons were obtained with the Student's t-test or one-way ANOVA followed by a Bonferroni test. P values of Ͻ0.05 were considered significantly different.
RESULTS
Channels that are comprised solely of ␣-and ␤-subunits (␣␤-channels) exhibit properties that differ from ␣␥-and ␣␤␥-channels, including a high P o and a reduced sensitivity to amiloride (12, 20) . To determine which region of the ␥-subunit is responsible for restraining channel activity and enhancing amiloride sensitivity, a series of ␥-␤-chimeras were generated by replacing the specific regions in the ␥-subunit with the corresponding ␤-subunit regions: ␥-␤NTM1 (␤1-78 and ␥81-566), ␥-␤ECD (␥1-80, ␤79 -505, and ␥523-655), and ␥-␤TM2C (␥1-522 and ␤506 -638; see EXPERIMENTAL PROCEDURES and Fig. 1A ). ␥-␤NTM1 and ␥-␤ECD generated minimal currents when coexpressed with wild-type ␣-and ␤-subunits, similar to what we observed in oocytes expressing only ␣-and ␤-subunits. In con- TM1 and TM2 are noted. B: oocytes that express ␣␤-channels, ␣␤␥-channels, or channels comprising of ␣-and ␤-subunits and a set of ␥-␤-chimeric constructs were clamped at Ϫ100 mV to measure whole cell Na ϩ currents. After basal currents were obtained, oocytes were perfused with 10 M benzamil to determine the benzamil-insensitive component of the whole cell current. Data were gathered from multiple batches of oocytes from different frogs (n ϭ 16 -51 for each group). Statistical significance was determined with one-way ANOVA followed by a Bonferroni test. *P Ͻ 0.05; ***P Ͻ 0.001, values that were significantly different from those of the ␣␤␥-channel.
trast, ␣␤␥-␤TM2C channels exhibited larger amiloride sensitive Na ϩ currents than ␣␤␥-channels (Fig. 1B) . The ␥-␤TM2C construct contains ␤-subunit residues starting in the region just preceding TM2 (␤12 and wrist), extending through TM2 and cytoplasmic COOH terminus (Fig. 1A) . Multiple lines of evidence suggest that the outer mouth of the channel pore contains residues from the TM2 domains that have key roles in channel gating and amiloride binding (16, 32, 36, 43) . Two additional chimeras, ␥-␤TM2 (␥1-522, ␤506 -546, and ␥565-655) and ␥-␤C (␥1-564 and ␤547-638) were generated and analyzed (see EXPERIMENTAL PROCEDURES and Fig.  1A ). Amiloride-sensitive Na ϩ currents were readily detected in oocytes expressing ␣␤␥-␤TM2 channels or ␣␤␥-␤C channels, suggesting that both ␥-␤TM2 and ␥-␤C were components of functional channel complexes. Interestingly, ␣␤␥-␤TM2 channels exhibited increased channel activity (higher Na ϩ currents) compared with wild-type ␣␤␥-channels. In contrast, ␣␤␥-␤C channels exhibited reduced channel activity compared with wild-type channels (Fig. 1B) .
ENaCs are inhibited by external Na ϩ , a process referred to as Na ϩ self-inhibition that reflects a reduction in channel P o (10, 16, 17, 24, 34) . When assessing the P o and the Na ϩ self-inhibition response of a series of ENaC mutants, we observed a linear correlation between the magnitude of the Na ϩ self-inhibition response and P o (24). We used Na ϩ selfinhibition as a surrogate for channel P o . Na ϩ self-inhibition was assessed by initially bathing oocytes in a low [Na ϩ ] bath and rapidly changing to high [Na ϩ ] bath while measuring ENaC currents (16, 33) . This leads to a rapid increase in current due to the chemical driving force, which then falls to a steady state as the channel is inhibited by external Na ϩ (33) (Fig. 2) . Previous studies suggest that channels with a high intrinsic P o are less sensitive to extracellular Na ϩ (9, 24, 31, 45) and stimulation by mechanical forces (7, 8) . As shown in Fig. 2 , we observed that the Na ϩ self-inhibition response was largely diminished with ␣␤␥-␤TM2C as well as ␣␤␥-␤TM2 channels, suggesting that these channels have a high P o , when compared with ␣␤␥-channels. In contrast, ␣␤␥-␤C channels exhibited an enhanced Na ϩ self-inhibition response suggesting that they reside in a lower P o state.
We have previously shown that LSS activates ENaC by increasing channel P o and that channels with mutations that result in a high intrinsic P o have a blunted response to LSS (7, 8) . We observed that the activation of ␣␤␥-␤TM2 channels by LSS was largely blunted when compared with wild-type channels (Fig. 3) , suggesting that ␣␤␥-␤TM2 channels reside at a high P o state. These changes in Na ϩ self-inhibition and LSS responses observed with ␣␤␥-␤TM2 channels suggest that the TM2 region in the ␥-subunit dampens channel P o , preventing channels from residing in a high P o state.
In addition, the apparent amiloride binding affinity was reduced in ␣␤␥-␤TM2 channels, as shown by a large rightward shift in the amiloride dose-response curves (Fig. 4) . The IC 50 of amiloride inhibition for ␣␤␥-␤TM2 channels was 6.6 Ϯ 0.7 M, compared with a value of 0.07 Ϯ 0.01 M for ␣␤␥-channels. These properties, a presumed high P o and a reduced sensitivity to amiloride, have been observed in heterologously expressed ␣␤-channels (12). Our results suggest that the porelining region of the ␥-subunit has a key role in restraining channel activity (i.e., reducing channel P o ) and enhancing amiloride potency.
Mutations of ␥-subunit pore-lining residues alter the channel response to external Na ϩ . The pore-forming regions, primarily comprised of the TM2 domains, are highly conserved between ␤ and ␥-subunits (see Fig. 5A ). While ␣␤␥-␤TM2 Fig. 2 . Na ϩ self-inhibition is reduced in ␣␤␥-␤TM2C and ␣␤␥-␤TM2 channels A: representative recordings of the Na ϩ self-inhibition response of wild-type or mutant channels are shown. At t ϭ 20 s, bath perfusion with 1 mM Na ϩ (open bar) was switched to 110 mM Na ϩ (grey bar) to initiate the Na ϩ self-inhibition response. B: extent of channel inhibition by Na ϩ (Iss/Ipeak) is illustrated. The peak current (Ipeak) was the maximal inward current immediately after bath exchange. The steady-state current (Iss) was measured 40 s after Ipeak. C: time constants of current decay (-values) were estimated as described in the EXPERIMENTAL PROCEDURES. A total of 42 recordings of wild-type channels and 14 -40 recordings of mutant channels were collected. *P Ͻ 0.05, statistical significance between ␣␤␥-channels and mutant channels, as determined by one-way ANOVA followed by a Bonferroni test. channels displayed characteristics reminiscent of ␣␤-channels, residues known to have important roles in channel gating (i.e., the degenerin site; Refs. 5, 16, 19, 36, 42) and amiloride block (i.e., the amiloride binding site; Refs. 18, 20, 32) are identical in the ␤-and ␥-subunits (Fig. 5A) . Thus, we hypothesize that other residues within the pore of the ␥-subunit influence channel gating (as assessed by Na ϩ self-inhibition) and amiloride block. To identify these residues, we examined a panel of ␥-␤TM2 chimeras where sites within the TM2 region of the ␥-␤TM2 construct were replaced with the corresponding ␥-subunit residues. Sites were identified by their residue number in the linear ␥-subunit sequence (see Fig. 5A ). One construct, ␥-␤TM2-546/7 (G546S/G547C), failed to generate amiloride-sensitive Na ϩ currents when coexpressed with wildtype ␣-and ␤-subunits. Most of the constructs exhibited a marked reduction in the Na ϩ self-inhibition response compared with ␣␤␥-channels, similar to that seen with ␣␤␥-␤TM2 channels (Fig. 5B) . However, the ␣␤␥-␤TM2-531/2 (V531E/ W532M) channel exhibited a moderate Na ϩ self-inhibition response, with an I ss /I peak value significantly lower than that of the ␣␤␥-␤TM2 channel (Fig. 5B) .
If these two sites in the ␥-subunit, E531 and M532, have important roles in dampening channel P o , mutating these residues in the ␥-subunit to their corresponding ␤-subunit residues (i.e., ␥E531V/M532W) should result in a loss of Na ϩ self-inhibition. Indeed, this is what we observed. The Na ϩ self-inhibition response of ␣␤␥531/2 (E531V/M532W) channels was largely abolished, compared with ␣␤␥-channels, but was similar to that of ␣␤␥-␤TM2 channels (Fig. 5B) . We generated two additional mutants, ␥E531V and ␥M532W, and compared their response to external Na ϩ to that of the wildtype channel. The channel Na ϩ self-inhibition response was significantly reduced in ␣␤␥E531V channels but not in ␣␤␥M532W channels (Fig. 5B) . These results suggest that ␥E531 has an important role in reducing channel P o in response to external Na ϩ . We then systemically examined the role of the nonconserved ␥-subunit pore-lining residues in the channel's response to external Na ϩ . A series of mutants were generated by replacing nonconserved ␥-subunit TM2 residues with their corresponding ␤-subunit residues (Fig. 6) . The Na ϩ self-inhibition response of each mutant was examined. We found that the magnitude and/or time constant of the Na ϩ self-inhibition response was altered with several mutants. The Na ϩ self-inhibition response was reduced in four mutants (␣␤␥S529N, ␣␤␥E531V, The magnitude of channel activation by LSS was assessed as the benzamil-sensitive Na ϩ current (ILSS)/basal benzamil-sensitive current (Ibasal) value. The peak response of the ILSS following the initiation of LSS was normalized to the Ibasal before initiation of LSS. C: time constants of current increase (-values) were obtained as previously described (41) . -Values were determined by fitting the first 40 s of current increase following the initiation of LSS. *P Ͻ 0.001, statistically significant differences between ␣␤␥-channels and ␣␤␥-␤TM2 channels, as determined by Student's t-test (n ϭ 11 for each group). Fig. 4 . Amiloride dose-response curves. Whole cell Na ϩ currents were measured in oocytes expressing wild-type (OE) or ␣␤␥-␤TM2 () channels in the presence of increasing concentrations of amiloride. Currents were normalized to the basal current in the absence of amiloride to obtain normalized whole cell currents (I/I0) values. Each data point represents the mean value from 7 to 18 measurements Ϯ SE. Data were fit to the equation described in EXPERIMENTAL PROCEDURES. Error bars are within symbols.
␣␤␥S546G, and ␣␤␥V550L) but was enhanced in another three mutant channels ␣␤␥L541F, ␣␤␥C547G, and ␣␤␥I555F (Figs. 5 and 6 ). Interestingly, these sites are scattered throughout the region in the ␥-subunit immediately preceding and encompassing TM2. ␥S529 and ␥E531 precede the degenerin site (␥S535). Two Leu residues (␥L541 and ␥L543) flank the putative amiloride binding site (␥G542). ␥S546 and ␥C547 are within the selective filter. ␥V550 and ␥I555 are in the distal part of TM2.
Multiple sites within ␥TM2 contribute to the high sensitivity to amiloride seen in ␣␤␥-channels. The amiloride IC 50 value of ␣␤␥-␤TM2 channels (6.6 M) is ϳ100-fold higher than that of ␣␤␥-channels (0.07 M, see Table 1 and Fig. 4) . A conserved Gly residue in ␤-and ␥-subunits was previously shown to have a key role in the amiloride-dependent block of ENaC activity (18, 20, 32, 35) . We examined whether other sites within the ␥-subunit TM2 domain were required for the high potency of amiloride observed with ␣␤␥-channels. We generated a panel of ␥-subunit mutants where nonconserved sites within ␥TM2 were replaced with their corresponding ␤-subunit residues (see Table 1 ). We found that substitutions at one or two neighboring sites within ␥TM2 had only modest effects on amiloride potency, whereas the introduction of multiple substitutions had a cumulative effect on the amiloride IC 50 (Fig. 7 and Table 1 ). When 12 ␥-subunit residues spanning S529 through I556 were mutated to their corresponding ␤-subunit residues (␥529-56), the amiloride IC 50 value of the mutant channel, ␣␤␥529-56 (3.3 M) was comparable to that of the ␣␤␥-␤TM2 channel (6.6 M, Table 1 and Fig.  7) . Our results suggest that, in addition to the key Gly residue (␥G542), amiloride potency is determined by multiple sites within ␥TM2.
DISCUSSION
ENaC activity is regulated by a number of factors that affect either channel density at the cell surface, channel P o , or both (2, 16, 17, 39) . Three homologous ENaC subunits have different roles in channel regulation by various factors. For example, Fig. 5 . ␥E531 restrains the activity of wild-type channels. A: sequence alignments of the swapped regions within ␥-␤TM2 and the wild-type ␥-subunit. Identical residues are indicated with a grey background. TM2 residues are within the box. The degenerin (DEG) site, putative amiloride binding site, and selectivity filter are noted. B: amiloride-sensitive Iss/Ipeak values of channels with ␥-␤TM2, ␥-␤TM2 mutants, a wild-type ␥-subunit, or ␥-subunit mutants are shown (n ϭ 9 to 24 for each group from a minimal of 2 batches of oocytes; nd, not determined). *P Ͻ 0.05, channels with an Iss/Ipeak value significantly different than the ␣␤␥-␤TM2 channel. #P Ͻ 0.05, channels with an Iss/Ipeak value significantly different than the ␣␤␥-channel. Statistical significance was determined by one-way ANOVA followed by a Bonferroni test. Fig. 6 . Multiple residues within the ␥-subunit contribute to the channel's response to external Na ϩ . A: amiloride-sensitive Iss/Ipeak ratios (left) and time constants of current decay (, right) of wild-type channels or channels with selected ␤-subunit residues substituted into the ␥-subunit (at the indicated sites) were determined. Dashed lines represent the average values of ␣␤␥-␤TM2 channels from 45 observations (oocytes harvested from nine frogs). The average values of wild-type channels are from 31 observations (9 batches of oocytes), whereas mutant data are from 9 to 14 observations from 2 or 3 batches of oocytes. Values that were significantly different from that of the wild-type channel (*P Ͻ 0.05, determined by one-way ANOVA followed by a Bonferroni test) are shown as black (decreased value) or white (increased value) bars. the ␣-and ␥-subunits are processed by proteases, and the release of embedded inhibitory tracts activates the channel by increasing its P o (3, 6, 13, 22, 29, 30) . Palmitoylation of the ␤-subunit (␤C43 and ␤C557) modulates channel gating, likely by facilitating its interaction with membrane lipids (28) .
Prototypic channels composed of all three subunits exhibit a lower P o and higher sensitivity to amiloride compared with channels comprised solely of ␣-and ␤-subunits (12), suggesting that there are sites within the ␥-subunit that dampen P o . Our analyses of a series of ␥-subunit chimeras where regions of the ␥-subunit were replaced with the corresponding regions of the ␤-subunit, using Na ϩ self-inhibition as a surrogate measurement of channel P o (24) , suggested that the region immediately preceding and containing the ␥-subunit TM2 domain was responsible for the differences in the P o and amiloride potency observed with ␣␤-and ␣␤␥-channels. Channels with the ␥-␤TM2 construct exhibited a higher basal activity and a markedly blunted Na ϩ self-inhibition response and LSS response, consistent with a high baseline channel P o (Figs. 1-3) . The loss of inhibition by extracellular Na ϩ seen with the ␣␤␥-␤TM2 channel was partially rescued by introducing a pair of ␥-subunit residues, E531 and M532, into ␥-␤TM2 (Fig. 5) . Furthermore, replacing these two sites in the ␥-subunit with their corresponding ␤ residues caused a loss of Na ϩ self-inhibition 
values of amiloride block of whole cell Na ϩ currents of ␣␤␥-channels or noted mutant channels are expressed as means Ϯ SE. Statistic significance was analyzed with one-way ANOVA followed by a Bonferroni's test (*P Ͻ 0.01; †P Ͻ 0.001 vs. ␣␤␥-channels). The n indicates the number of individual measurements for each data point used to generate the amiloride dose-response curve. Data used to generate Figs. 4 and 7 were grouped to calculate the IC50 values of ␣␤␥-channel and ␣␤␥-␤TM2 channel. Fig. 7 . Multiple sites within the TM2 domain of the ␥-subunit facilitate high affinity amiloride block. A: sequence alignments of the pore-forming regions of ␤-and ␥-subunits (see Fig. 5 legend) . B: dose-response curves of amiloride block of ␣␤␥-or mutant channels, where multiple sites within the ␥-subunit were replaced by equivalent ␤-subunit residues (see Table 1 ). Na ϩ currents were normalized to the basal current in the absence of amiloride to obtain I/I0 values. Each data point represents the mean value from 5 to 25 measurements Ϯ SE. Wild-type and ␣␤␥-␤TM2 dose-response data in this figure were obtained from different groups of oocytes that were used to generate the data presented in Fig. 4 . Data were fit to the equation described in EXPERIMENTAL PROCEDURES. (Fig. 5) , a characteristic observed with the ␣␤␥-␤TM2 channel. Both sites, ␥531 and ␥532, are located within the vicinity of the channel gate based on previous functional studies and the resolved ASIC1 structures (1, 15, 16, 19, 36, 43) .
In assessing the roles of individual residues that were not conserved between ␤-and ␥-subunits, residues at positions ␥529, ␥531, ␥546, and ␥550 appeared to have important roles in enhancing the Na ϩ self-inhibition response. Substitutions of the corresponding ␤-subunit residue at these sites led to a marked loss in Na ϩ self-inhibition (Figs. 5 and 6 ). Our observations suggest that the pore-forming region of the ␥-subunit restrains the activity of ␣␤␥-channels to a moderate P o state and are consistent with previous studies where mutations introduced in the TM2 regions of each of the three ENaC subunits have profound effects on channel activity (16, 19, 35, 36, 43) . While the effects of mutations in the TM2 regions on Na ϩ self-inhibition have not previously been systematically addressed, we have noted modest effects with mutations introduced in the region immediately following TM1 and preceding TM2 on Na ϩ self-inhibition (40) . One of the characteristic features of members of the ENaC/ degenerin ion channel family is a high sensitivity to amiloride. A conserved site within the TM2 region of each subunit (␣S583, ␤G525, and ␥G542 in mouse ENaC) has been proposed to bind amiloride, as specific mutations introduced at this site in any of the three subunits resulted in a profound loss in amiloride sensitivity (18, 32) . We previously reported that selected mutations of residues in the selectivity filter of the ␣-or ␤-subunit were also associated with large increases in the amiloride IC 50 (23, 38) . While the key amiloride binding site in ␤-and ␥-subunits has a conserved Gly residue (Fig. 7A) , the amiloride IC 50 of ␣␤-channels is significantly higher than that of ␣␥ or ␣␤␥-channels (12, 20, 27) . We observed that the amiloride IC 50 of ␣␤␥-␤TM2 was nearly two orders of magnitude higher than that of ␣␤␥-channels (Table 1 and Fig. 4) , similar to the value reported for ␣␤-channels (27) . To identify sites in the ␥-subunit that are involved in amiloride binding, in addition to ␥G542, we determined the amiloride IC 50 for a panel of mutants where one or multiple sites within the ␥-subunit TM2 domain were replaced with their corresponding ␤-subunit residues. Single substitutions within the ␥-subunit TM2 did not reduce the amiloride potency to the extent seen with mutations at the putative amiloride binding site (␥G542 ;  Table 1 ). However, we observed a cumulative effect of substitutions on amiloride potency (Table 1) . A mutant bearing substitutions at 12 sites within the ␥-subunit, ␣␤␥529-556, had an amiloride IC 50 comparable to that of ␣␤␥-␤TM2 channels (Table 1 and Fig. 7) . Our results are consistent with a previous work suggesting that differences in the amiloride IC 50 of rat ␣␤-and ␣␤␥-channels were conferred by residues in a stretch of 15 amino acids (residues 531 to 545) that are within ␥TM2 (27) . These results suggest that, in addition to the well-characterized amiloride binding site, multiple residues within the TM2 domains of ENaC subunits influence amiloride potency (38) .
The fact that ␣␤␥-␤TM2 channels exhibit a high P o and reduced amiloride potency, consistent with the behavior of ␣␤-channels, suggests that ␣␤ channels have a subunit stoichiometry of one ␣-and two ␤-subunits. However, we cannot rule out a subunit stoichiometry of two ␣-and one ␤-subunits. In summary, analyses of ␣␤␥ and ␣␤␥-␤TM2 channels allowed us to identify key sites within the TM2 domain of the ␥-subunit (␥S529, ␥E531, ␥S546, and ␥V550) that restrain channel activity. Furthermore, in addition to the amiloridebinding site (␥G542) there are multiple residues in the TM2 region of the ␥-subunit that, as a group, contribute to the high amiloride potency of ␣␤␥-channels. The TM2 regions within individual subunits are well conserved across species. As the TM2 regions of human and mouse ␥-subunit are identical, it is likely that the sites we found in the mouse ␥-subunit TM2 region that either restrain channel activity or contribute to amiloride potency will have similar roles in the human ␥-subunit.
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